Selank Amidate · Research brief

What Is Selank? Research Compound Profile & Safety

Real Peptides Research TeamEditorial

Updated September 28, 20269 min read

52 WORDS

Short answer

Selank wasn't designed as a nootropic. It was designed as a stability fix. Chemists at the Institute of Molecular Genetics of the Russian Academy of Sciences started with tuftsin, a four-amino-acid immune peptide the body already produces, and attached a Pro-Gly-Pro tail so plasma enzymes would take longer to chew it apart.

Key takeaways

Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, created by extending the natural immune tetrapeptide tuftsin with a Pro-Gly-Pro tail that slows enzymatic breakdown.
N-Acetyl Selank Amidate differs from Selank by two terminal caps, an acetyl group and an amide group, which block aminopeptidase and carboxypeptidase attack respectively.
Selank research products are not FDA-approved drugs and are supplied strictly for laboratory research, never for human or veterinary consumption.
HPLC purity and net peptide content measure different things, and a vial reading 98% pure can still contain less peptide by mass than the label implies.
Lyophilised peptide is typically held at -20°C or colder, while solutions are refrigerated at 2–8°C, protected from light, and aliquoted to avoid repeated freeze-thaw cycles.
Surface adsorption to glass and polypropylene is an invisible source of concentration loss in low-concentration peptide work and a frequent cause of unexplained variance.

Our team ships selank research products to laboratories constantly, and the questions we field are rarely about neurochemistry. They're about purity, terminal chemistry, and whether the material in the vial matches the certificate that came with it. That's the right instinct.

What are selank research products?

Selank research products are research-use-only preparations of a synthetic heptapeptide, sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from the endogenous tetrapeptide tuftsin. They are supplied as lyophilised powder, as a liquid spray, or as the modified analog N-Acetyl Selank Amidate, commonly in vial sizes from 5mg to 30mg. None of them are FDA-approved drugs.

The common over-simplification is that Selank and N-Acetyl Selank Amidate are the same molecule in different packaging. They aren't. Capping the N-terminus with an acetyl group and the C-terminus with an amide changes which enzymes can attack the chain, which changes how the compound behaves in solution. This piece covers the sequence and reported mechanisms, why the amidate modification exists, and how to read a certificate before money changes hands.

The peptide behind the name

Selank is a synthetic heptapeptide built on tuftsin, the tetrapeptide Thr-Lys-Pro-Arg that occurs naturally as a fragment of the immunoglobulin G heavy chain. Tuftsin alone is fragile in plasma. The Pro-Gly-Pro extension added to the C-terminus slows enzymatic cleavage, and that is the entire reason the longer sequence exists. Molecular weight is commonly listed at roughly 752 Da on supplier documentation.

So what does the literature actually report? Published work, much of it from Russian research groups, describes several candidate mechanisms rather than one clean pathway. Animal studies report changes in the expression of GABA-A receptor subunits in brain tissue, shifts in serotonin and dopamine metabolism, inhibition of enkephalin-degrading enzyme activity in plasma, and altered expression of brain-derived neurotrophic factor and interleukin-6. Research suggests the anxiolytic-type effects described in that literature are downstream of a combination of these actions rather than a single receptor interaction. The mechanistic picture is genuinely incomplete.

Regulatory status matters more than mechanism for anyone sourcing the compound. Selank has been reported as registered for clinical use in Russia. It holds no US marketing authorisation and is not an FDA-approved drug. Every vial of selank research products sold here is sold for laboratory research only, never for human or veterinary consumption.

Anyone searching selank nootropic research will find an evidence base that is real but small, concentrated in a narrow research lineage, and thin on large independent replication. We say that plainly to customers, because a lab planning a study deserves to know how much scaffolding already exists.

Why the amidate modification exists

N-Acetyl Selank Amidate is the same core sequence carrying two terminal changes: an acetyl cap on the N-terminus and an amide cap on the C-terminus. Both caps exist to block exopeptidases. Aminopeptidases attack free N-terminal amines and carboxypeptidases attack free C-terminal carboxyl groups, so capping both ends removes the two most convenient enzymatic entry points. That is why the amidate form dominates selank research, and why the selank amidate 30mg research peptide format is the one most labs ask about when they need a longer window between preparation and readout. Labs running comparative work often bench it against Semax Amidate, which shares the same Pro-Gly-Pro stabilising motif on a different parent sequence.

The handling failure nobody warns you about

The biggest source of variance in small-peptide work isn't temperature. It's surface adsorption. At low working concentrations a meaningful fraction of a peptide this small can stick to borosilicate glass and polypropylene walls, so the concentration in the pipette is quietly lower than the concentration on the label, and nothing about the solution looks wrong. Low-binding tubes, a carrier protein where the assay tolerates one, and fewer transfers all reduce the loss.

Freeze-thaw cycling is a close second. Lyophilised material is generally held at -20°C or colder; once in solution, refrigeration at 2–8°C with protection from light is standard laboratory practice, and aliquoting before freezing stops a single vial being cycled repeatedly. Vigorous vortexing foams peptide solutions and shears the chain, so swirling is the safer habit. Stability expectations also differ across selank research products: dry powder, reconstituted solution, and pre-mixed spray do not share one profile.

Reading the certificate before money changes hands

A certificate of analysis is the only part of a peptide purchase a buyer can verify independently, and most people read the wrong number on it. HPLC purity tells you what proportion of the peptide present is the correct peptide. Net peptide content tells you how much of the vial's mass is peptide at all, the remainder being residual water and counterion, usually trifluoroacetate left behind from purification. A vial can read 98% pure by HPLC and still hold less peptide by mass than the label suggests, because those two figures answer completely different questions.

A usable certificate shows a chromatogram with a purity figure, mass spectrometry confirming the expected molecular ion, a batch number, and an analysis date. A weak one is a generic template with no batch number, or a batch number that doesn't match the vial in your hand. When those don't match, the document certifies nothing at all.

This is where sourcing for selank research products separates cleanly. Real Peptides synthesises in small batches with exact amino-acid sequencing and publishes batch certificates of analysis so arriving material can be checked against tested material. Anyone planning to buy selank research peptide should treat that document as part of the product rather than as paperwork.

One boundary is worth stating flatly. These compounds are not sold for human or veterinary consumption, and if a question concerns an animal's health, talk to your veterinarian rather than a research catalogue. Study parameters described in published selank dosage research are experimental design details, not instructions for anyone.

Selank Research Products: Format Comparison

Three presentations dominate the catalogue, including the Selank Liquid Spray 45mg, and they differ in stability, preparation work, and the kind of lab they suit. This table compares them on the factors that actually change a study's logistics.

Format	Terminal chemistry	Preparation and stability	Where it fits in research	Bottom line
Lyophilised Selank, unmodified	Free N-terminus and free C-terminus	Longest dry shelf life when held frozen; needs reconstitution and aliquoting before any work begins	Baseline sequence work and direct comparison against the native peptide	Correct choice when the study requires the unmodified molecule and the lab can reconstitute cleanly
N-Acetyl Selank Amidate, lyophilised	Acetylated N-terminus, amidated C-terminus	Same dry storage requirements, with greater reported resistance to exopeptidase cleavage once in solution	Work where enzymatic degradation inside the assay window is the limiting variable	The default format for most labs asking about na selank amidate research
Selank liquid spray	Varies by product, supplied already in solution	No reconstitution step; refrigerated storage and light protection apply from the moment it arrives	Screening and handling-limited setups where preparation error is the main risk	Fewest handling steps and the shortest usable window, suited to labs without aliquoting capacity

What If: Sourcing and Handling Scenarios

What if a vial arrives warm after shipping?

Quarantine the vial, photograph the packaging, and contact the supplier before opening anything. Lyophilised peptide is considerably more tolerant of short ambient excursions than material in solution, which is exactly why most research-grade peptide ships dry, but tolerance is not the same as documented integrity. A supplier that keeps batch records can tell you what the retained sample looks like; one that cannot is telling you something else entirely.

What if the powder is barely visible in the vial?

Don't assume the vial is short. Lyophilised peptide at low fill weights often presents as a thin film on the glass wall rather than a visible pellet, and the appearance depends on the freeze-drying cycle rather than the quantity present. The certificate and the gravimetric fill record are the reference, not the eye. Photographing the vial before reconstitution gives you something to compare against if a later question comes up.

What if a supplier markets the compound with human-use claims?

Walk away and document why. Selank research products carry no FDA approval for any human indication, so a supplier attaching consumption language to them is signalling a compliance posture that affects everything else in the operation, including how batches get tested and recorded. Careful suppliers keep research framing consistent across the whole catalogue, from a single compound page to the wider research peptide range.

What if two batches behave differently in the same assay?

Compare the two certificates side by side before touching the experimental design. Differences in net peptide content, counterion load, or residual moisture between batches shift the actual peptide mass delivered even when both labels read the same milligram figure. Batch-specific documentation exists precisely so this comparison is possible; generic template certificates make it impossible.

The unglamorous truth about the evidence base

Here's the honest answer: the question of whether Selank works has no settled answer yet, and anyone claiming otherwise is selling something. The published record is real, it includes human clinical work conducted in Russia, and it reports anxiolytic-type effects with good tolerability in those trials. It is also a small record, concentrated in a narrow set of research groups, and short on large independent replication outside that lineage. That describes a compound worth studying, not a demonstrated result. Nothing here is medical advice, and selank research products remain unapproved by the FDA for any human indication.

Selank research products occupy an unusual position: a peptide with decades of investigation behind it and a surprisingly thin English-language file in front of it. That gap is the genuinely interesting part. The entire design story of this molecule is about buying time against enzymes, first with a Pro-Gly-Pro tail, later with capped termini, and the labs that carry that same logic into their handling get cleaner data than the ones that don't. Chemistry engineered for stability deserves to be stored like it.

References

Peer-reviewed sources on Selank indexed in PubMed, listed for research context. Real Peptides supplies Selank for laboratory research use only.

Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bulletin of experimental biology and medicine, 2022. PMID 36322304. doi:10.1007/s10517-022-05624-x
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Current reviews in clinical and experimental pharmacology, 2021. PMID 32621722. doi:10.2174/1574884715666200704152810
Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318. doi:10.1134/S001249662001007X
Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bulletin of experimental biology and medicine, 2020. PMID 32651826. doi:10.1007/s10517-020-04868-9
Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bulletin of experimental biology and medicine, 2019. PMID 31625062. doi:10.1007/s10517-019-04588-9
Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress. Bulletin of experimental biology and medicine, 2019. PMID 31243679. doi:10.1007/s10517-019-04512-1
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and peptide letters, 2018. PMID 30255741. doi:10.2174/0929866525666180925144642
Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress. Bulletin of experimental biology and medicine, 2017. PMID 28853100. doi:10.1007/s10517-017-3817-8

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, created by extending the natural immune tetrapeptide tuftsin with a Pro-Gly-Pro tail that slows enzymatic breakdown. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and is supplied in the US strictly as a research-use-only compound.

Safety has not been established by the FDA, which has not approved Selank for any human indication. Russian clinical literature reports it was generally well tolerated in the trials conducted there, though that record is small and largely from one research lineage. Selank research products are sold for laboratory research only, not for consumption.

Published research reports anxiolytic-type effects in animal models and in human clinical work conducted in Russia, alongside changes in GABA-A receptor subunit expression, monoamine metabolism, and BDNF expression. The evidence is real but limited, concentrated in a narrow set of research groups, and lacks large independent replication. No outcome can be promised.

The unmodified peptide is reported in the literature to degrade rapidly in plasma through exopeptidase activity, and published half-life figures vary enough by assay method that no single number is reliable to quote. N-Acetyl Selank Amidate carries terminal caps specifically intended to slow that cleavage, which is the main reason labs select it.

There is no time-to-effect figure that applies to any person, because Selank is not an approved medicine and Real Peptides supplies it for laboratory research only. Published studies use observation windows that differ substantially by model, endpoint, and route studied. Those windows are study design parameters rather than anything transferable outside the research setting.

Real Peptides does not provide administration guidance, because Selank is a research-use-only compound with no FDA approval for human or veterinary use. Published studies describe intranasal and injectable routes used in laboratory conditions, and those descriptions are experimental design details. Handling questions about storage, reconstitution, and purity verification are the appropriate ones for a research supplier.

They share the same core heptapeptide sequence, but N-Acetyl Selank Amidate carries an acetyl group on the N-terminus and an amide group on the C-terminus. Those caps block aminopeptidase and carboxypeptidase attack, giving the modified analog greater reported resistance to enzymatic cleavage in solution. That stability difference, not potency marketing, is why most labs choose the amidate form.

Selank research products are sold by research chemical suppliers to researchers and laboratories, not through pharmacies, because the compound has no marketing authorisation as a medicine. Real Peptides synthesises small batches with exact amino-acid sequencing and publishes batch certificates of analysis so the arriving vial can be checked against the tested material.

Lyophilised peptide is generally held at -20°C or colder, protected from light and moisture. Once in solution, refrigeration at 2–8°C is standard practice, with aliquoting before freezing so one vial is not subjected to repeated freeze-thaw cycles. Vigorous vortexing foams peptide solutions and shears the chain, so gentle swirling is preferred.

Published studies report quantities used in specific animal models and clinical settings under defined conditions. Those figures are experimental design parameters tied to the species, route, and endpoint of each study. They do not transfer to any other setting, and a legitimate research supplier will not reframe them as instructions for a person.

Yes. A spray arrives already in solution, which removes the reconstitution step but starts the refrigerated, light-protected clock immediately on delivery. A lyophilised vial has the longer dry shelf life when kept frozen but requires correct reconstitution and aliquoting. The choice usually depends on whether a lab has reliable cold-chain and aliquoting capacity.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA